B1 and B2 kinin receptor participation in hyperproliferative and inflammatory skin processes in mice

Journal of Dermatological Science

Volumn 64, Issue 1, 2011, Pages 23-30

  Pietrovski, Evelise Fernandes ^a   Paludo, Kátia Sabrina ^a   Mendes, Daniel Augusto Gasparin Bueno ^a   de Souza Fonseca Guimarães, Fernando ^a   Veiga, Silvio Sanchez ^a   de Freitas Buchi, Dorly ^a   Fonseca, Raphael Gomes ^b   Zampronio, Aleksander Roberto ^a   Bader, Michael ^c   Pesquero, João Bosco ^b   Ferreira, Juliano ^d   Otuki, Michel Fleith ^e   Cabrini, Daniela Almeida ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^e STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Epidermis hyperproliferation; FR 173657; Kinin receptor; Kinin receptor knockout mice; SSR 240612

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; CYCLINE; DERMATOLOGICAL AGENT; KININ B1 RECEPTOR; KININ B2 RECEPTOR; RECEPTOR PROTEIN; SSR 240612; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; 2 ((3 (1,3 BENZODIOXOL 5 YL) 3 (((6 METHOXY 2 NAPHTHYL)SULFONYL)AMINO)PROPANOYL)AMINO) 3 (4 ((2,6 DIMETHYLPIPERIDINYL)METHYL)PHENYL) N ISOPROPYL N METHYLPROPANAMIDE; 2-((3-(1,3-BENZODIOXOL-5-YL)-3-(((6-METHOXY-2-NAPHTHYL)SULFONYL)AMINO)PROPANOYL)AMINO)-3-(4-((2,6-DIMETHYLPIPERIDINYL)METHYL)PHENYL)-N-ISOPROPYL-N-METHYLPROPANAMIDE; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; QUINOLINE DERIVATIVE; SULFONAMIDE;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KNOCKOUT MOUSE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIASIS; SKIN INFLAMMATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; INFLAMMATION; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CELL PROLIFERATION; DIOXOLES; FEMALE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROLIFERATING CELL NUCLEAR ANTIGEN; QUINOLINES; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SKIN DISEASES; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 80052381195     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.06.016     Document Type: Article

References (30)

1. Fang M., Wee S.A., Ronski K., Fan H., Tao S., Lin Q. Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases. Genomic Med 2007, 1:75-85.
2. Ayli E.E., Li W., Brown T.T., Witkiewicz A., Elenitsas R., Seykora J.T. Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders. J Cutan Pathol 2008, 35:273-277.
3. Jean J., Lapointe M., Soucy J., Pouliot R. Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci 2009, 53:19-25.
4. Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
5. Schön M.P., Boehncke W.H. Psoriasis. N Engl J Med 2005, 352:1899-1912.
6. Nickoloff B.J., Bonish B.K., Marble D.J., Schriedel K.A., Dipietro L.A., Gordon K.B., et al. Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J Investig Dermatol Symp Proc 2006, 11:16-29.
7. Gottlieb A.B. Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov 2005, 4:19-34.
8. Schremmer-Danninger E., Hermann A., Fink E., Fritz H., Roscher A.A. Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases. Immunopharmacology 1999, 43:287-291.
9. Schremmer-Danninger E., Naidoo S., Neuhof C., Valeske K., Snyman C., Sander C., et al. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases. Biol Chem 2004, 385:1069-1076.
10. Pietrovski E.F., Otuki M.F., Regoli D., Bader M., Pesquero J.B., Cabrini D.A., et al. The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation. Regul Pept 2009, 152:67-72.
11. Poblete M.T., Reynolds N.J., Figueroa C.D., Burton J.L., Muller-Esterl W., Bhoola K.D. Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br J Dermatol 1991, 124:236-241.
12. Campos M.M., Leal P.C., Yunes R.A., Calixto J.B. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 2006, 27:646-651.
13. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57:7-77.
14. Calixto J.B., Medeiros R., Fernandes E.S., Ferreira J., Cabrini D.A., Campos M.M. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004, 143:803-818.
15. Chai K.X., Ni A., Wang D., Ward D.C., Chao J., Chao L. Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics 1996, 31:51-57.
16. Pesquero J.B., Araujo R.C., Heppenstall P.A., Stucky C.L., Silva J.A., Walther T., et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 2000, 97:8140-8145.
17. Rupniak N.M., Boyce S., Webb J.K., Williams A.R., Carlson E.J., Hill R.G., et al. Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain 1997, 71:89-97.
18. Cayla C., Todiras M., Iliescu R., Saul V.V., Gross V., Pilz B., et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 2007, 21:1689-1698.
19. Stanley P.L., Steiner S., Havens M., Tramposch K.M. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol 1991, 4:262-271.
20. Medeiros R., Otuki M.F., Avellar M.C., Calixto J.B. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Eur J Pharmacol 2007, 559:227-235.
21. Gábor M. Mouse ear inflammation models. Mouse ear inflammation models and their pharmacological applications 2000, 15-33. Akadémiai Kiadó, Budapeste. M. Gábor (Ed.).
22. Madeddu P., Varoni M.V., Palomba D., Emanueli C., Demontis M.P., Glorioso N., et al. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 1997, 96:3570-3578.
23. Duka I., Kintsurashvili E., Gavras I., Johns C., Bresnahan M., Gavras H. Vasoactive potential of the B(1) bradykinin receptor in normotension and hypertension. Circ Res 2001, 88:275-281.
24. Gambichler T., Bischoff S., Bechara F.G., Altmeyer P., Kreuter A. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci 2008, 49:125-132.
25. Schremmer-Danninger E., Heinz-Erian P., Topfer-Petersen E., Roscher A.A. Autoradiographic localization and characterization of bradykinin receptors in human skin. Eur J Pharmacol 1995, 283:207-216.
26. Bhoola K.D., Figueroa C.D., Whorthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992, 44:1-80.
27. Johnson R.M., King K.L., Morhenn V.B. Comparison of second messenger formation in human keratinocytes following stimulation with epidermal growth factor and bradykinin. Second Messengers Phosphoproteins 1992, 14:21-37.
28. Jung E.M., Betancourt-Calle S., Mann-Blakeney R., Griner R.D., Bollinger Bollag W. Sustained phospholipase D activation is associated with keratinocyte differentiation. Carcinogenesis 1999, 20:569-576.
29. Vidal M.A., Astroza A., Matus C.E., Ehrenfeld P., Pavicic F., Sanchez T., et al. Kinin B2 receptor-coupled signal transduction in human cultured keratinocytes. J Invest Dermatol 2005, 124:178-186.
30. Coutant K.D., Ryder N.S. Bradykinin upregulates immediate-early gene mRNA in human keratinocytes. Arch Dermatol Res 1996, 288:2-6.